Alan A. Moazzam , Stavros N. Savvas , Arun P. Amar , Sung W. Ham , Richard S. Panush , Leonardo C. Clavijo
{"title":"Diffuse aneurysmal disease – A review","authors":"Alan A. Moazzam , Stavros N. Savvas , Arun P. Amar , Sung W. Ham , Richard S. Panush , Leonardo C. Clavijo","doi":"10.1016/j.rvm.2013.11.003","DOIUrl":"10.1016/j.rvm.2013.11.003","url":null,"abstract":"<div><p>Aneurysmal disease in isolated vascular territories such as the aorto-iliac, cerebral, and peripheral systems is a well-described and frequent phenomenon. However, there is a paucity of literature addressing diffuse aneurysmal disease, a clinical entity involving simultaneous aneurysmal changes in multiple vascular territories. We present an illustrative case of a patient discovered to have aneurysmal disease in the aortic, peripheral, cerebral, and coronary vascular territories and review the available literature. We use this case to share insights into the diagnosis and management of this condition, and also to propose a rational diagnostic approach for similar patients.</p></div>","PeriodicalId":101091,"journal":{"name":"Reviews in Vascular Medicine","volume":"2 2","pages":"Pages 48-57"},"PeriodicalIF":0.0,"publicationDate":"2014-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rvm.2013.11.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82127912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Real risks and benefits of screening for abdominal aortic aneurysm in men","authors":"Lucinda Frank, Jonothan J. Earnshaw","doi":"10.1016/j.rvm.2013.10.004","DOIUrl":"10.1016/j.rvm.2013.10.004","url":null,"abstract":"<div><p><span>Ruptured abdominal aortic aneurysm (AAA) is responsible for the premature death of more than 4000 men per year in England and Wales (Anjum et al., 2012 </span><span>[1]</span>). The condition is appropriate for screening, with, the aim to prevent premature death from AAA rupture. Screening is the investigation of people for an, otherwise unsuspected condition. Screening for many diseases is currently popular among the lay, press, on the basis that prevention of a serious condition is better than cure. Yet all screening is a, balance of potential harms and benefits. Making an informed choice about attending screening requires, that invited subjects receive balanced information about both the pros and cons. Information given to invited subjects usually contains key facts such as the significant benefits and major harms. The aim of this article is to examine some of the less obvious consequences of accepting or declining the offer of screening for AAA. There are also more subtle advantages and hazards that are less easily communicated, that may have consequences beyond the individual.</p></div>","PeriodicalId":101091,"journal":{"name":"Reviews in Vascular Medicine","volume":"2 1","pages":"Pages 19-23"},"PeriodicalIF":0.0,"publicationDate":"2014-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rvm.2013.10.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73218581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Beatrice Forte, Cecilia Becattini, Giancarlo Agnelli
{"title":"Latest developments in antithrombotic therapy in patients with lower extremity arterial disease","authors":"M. Beatrice Forte, Cecilia Becattini, Giancarlo Agnelli","doi":"10.1016/j.rvm.2013.11.001","DOIUrl":"10.1016/j.rvm.2013.11.001","url":null,"abstract":"<div><p><span>Lower extremity arterial disease<span> (LEAD) is one of the manifestations of systemic atherosclerosis<span> causing the narrowing in the vessels of the lower limbs. Clinically it can go from an asymptomatic plaque to intermittent claudication<span> to critical limb ischemia, the most severe clinical manifestation. LEAD is associated with increased risk of other cardiovascular events such as myocardial infarction and </span></span></span></span>ischemic stroke<span><span>. The treatment of LEAD consists mainly in </span>revascularization<span> either by bypass surgery or endovascular procedures. Medical treatment also plays a major role at all stages of the disease. Amongst medical therapy anti-thrombotics are widely used for prevention of cardiovascular risk, in the prevention of re-stenosis/re-occlusion following surgical or endovascular revascularization and for symptom improvement.</span></span></p></div>","PeriodicalId":101091,"journal":{"name":"Reviews in Vascular Medicine","volume":"2 1","pages":"Pages 37-42"},"PeriodicalIF":0.0,"publicationDate":"2014-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rvm.2013.11.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79231526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Review of randomized controlled trials comparing endovenous thermal and chemical ablation","authors":"Bo Eklöf , Michel Perrin","doi":"10.1016/j.rvm.2013.10.001","DOIUrl":"10.1016/j.rvm.2013.10.001","url":null,"abstract":"<div><p>In the past decade, the development of minimally invasive correction of primary venous reflux<span><span> of the great saphenous vein (GSV) by endovenous techniques has provided a patient-friendly means to treat this disorder as an office- based procedure with ablation of the GSV using </span>radiofrequency<span> (RFA), laser (EVLA), or sclerotherapy<span>. What do the randomized controlled trials (RCT) teach us about these new endovenous procedures? There are 7 RCT's (493 patients) in 9 papers comparing RFA with open surgery (OS); 12 RCT's (2327 patients) in 16 papers comparing EVLA with OS; 5 RCT's (570 patients) comparing RFA with EVLA; 6 RCT's (699 patients) with modifications of EVLA; 2 RCT's (153 patients) in 3 papers comparing EVLA with cryostripping; 6 RCT's (1406 patients) in 7 papers comparing foam sclerotherapy with OS; 2 RCT's (166 patients) comparing EVLA with foam sclerotherapy; 1 RCT (580 patients) in 2 papers comparing RFA versus EVLA versus foam sclerotherapy versus OS.</span></span></span></p></div><div><h3>Conclusion</h3><p>Based on the presented RCT's with caveats mentioned in the paper, the differences between modern open surgery and the new endovenous procedures are insignificant and no treatment modality can be recommended as superior to another. Nevertheless it is established that chemical ablation is the cheapest, but redo-treatment is more frequent related to recurrence.</p></div>","PeriodicalId":101091,"journal":{"name":"Reviews in Vascular Medicine","volume":"2 1","pages":"Pages 1-12"},"PeriodicalIF":0.0,"publicationDate":"2014-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rvm.2013.10.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86921186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Management of venous thromboembolism in cancer patients","authors":"Axel C. Matzdorff, David Green","doi":"10.1016/j.rvm.2013.10.005","DOIUrl":"10.1016/j.rvm.2013.10.005","url":null,"abstract":"<div><p><span><span><span>Venous thromboembolism (VTE) in cancer patients is a common and severe clinical problem. The incidence of VTE has been rising as the number of cancer patients increases. Because the </span>pathophysiology<span> of thrombosis is multifactorial, there is no ‘one fits all’ prophylaxis or treatment. </span></span>Thromboprophylaxis<span><span> with a low molecular weight heparin<span> (LMWH) is recommended for hospitalized cancer patients unless contraindicated. However, thromboprophylaxis is not customarily advised for ambulatory cancer patients. Patients developing a VTE are usually treated with a LMWH, and this agent is continued long-term rather than switched to a vitamin K antagonist. The new </span></span>oral anticoagulants are currently not recommended for cancer patients until further experience with these </span></span>drugs<span> suggests otherwise. An increasing population of elderly patients, limited health care resources, and financial constraints will affect treatment options in the future. Prevention and treatment of VTE will be optimized when oncologists and patients become aware and fully informed about this disorder.</span></p></div>","PeriodicalId":101091,"journal":{"name":"Reviews in Vascular Medicine","volume":"2 1","pages":"Pages 24-36"},"PeriodicalIF":0.0,"publicationDate":"2014-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rvm.2013.10.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73449497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Nordic Walking: More effective than standard exercise programmes for claudicants?","authors":"C.E. Oakley , C.L. Spafford , J.D. Beard","doi":"10.1016/j.rvm.2013.10.003","DOIUrl":"10.1016/j.rvm.2013.10.003","url":null,"abstract":"","PeriodicalId":101091,"journal":{"name":"Reviews in Vascular Medicine","volume":"2 1","pages":"Pages 13-18"},"PeriodicalIF":0.0,"publicationDate":"2014-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rvm.2013.10.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87087088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Suzan W.I. Reeder , Céline Eggen , M. Birgitte Maessen-Visch , Kees-Peter de Roos , H.A. Martino Neumann
{"title":"Recurrence of venous leg ulceration","authors":"Suzan W.I. Reeder , Céline Eggen , M. Birgitte Maessen-Visch , Kees-Peter de Roos , H.A. Martino Neumann","doi":"10.1016/j.rvm.2013.08.002","DOIUrl":"10.1016/j.rvm.2013.08.002","url":null,"abstract":"<div><p>Published literature consists of a broad range of venous leg ulcer<span> (VLU) recurrence rates. Therefore, to assess the recurrence rate of VLU a search and review of published data was performed using the MEDLINE OvidSP, EMBASE, Web-of-Science, PubMed publisher and Cochrane Library<span>. The resulting data demonstrate VLU recurrence rates ranging from 0% at 6 months to 56% at 54 months. Two studies mention VLU recurrence at 60 months, with VLU recurrence rates of 19 and 48% respectively. Only three studies are comparable with regard to treatment and demonstrate VLU recurrence of 17, 17 and 25% at 12 months. In conclusion, this is the first study summarising high-level evidence with regard to VLU recurrence demonstrating a tendency that even after several years recurrence rates still increase. The results of this study, high recurrence rates indicate the need for new strategies after a VLU has healed.</span></span></p></div>","PeriodicalId":101091,"journal":{"name":"Reviews in Vascular Medicine","volume":"1 4","pages":"Pages 63-65"},"PeriodicalIF":0.0,"publicationDate":"2013-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rvm.2013.08.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87249863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Indications for stenting during thrombolysis","authors":"N. Bækgaard , S. Just","doi":"10.1016/j.rvm.2013.08.004","DOIUrl":"10.1016/j.rvm.2013.08.004","url":null,"abstract":"<div><p><span><span>Success after treatment with catheter-directed </span>thrombolysis<span> of deep venous thrombosis (DVT) in the iliofemoral vein segment is among other factors based on the stenting procedure of persistent obstructive lesions. This means opening of a chronic occlusion or stenotic appearance in the </span></span>iliac vein<span> in the so-called iliac vein compression syndrome also known as the May–Turner syndrome. It is demonstrated that restoration of the outflow tract for the entire lower limb is essential for an optimal result in the short run and to avoid the post thrombotic syndrome<span> later on. The stents available until now have been constructed for the arterial system, but stents designed for veins are under testing. It is important that a stent is flexible with radial force to overcome the external compression, curved system and caliber difference along the vein in this low-pressure system. Balloon dilatation<span> alone has now place in the vein structure due to wall collapse after deflation, but is only used in connection with the stenting procedure. Some technical aspects are described in details as well the considerations about the anticoagulation and flow accelerating maneuver under and after the procedure. The proportion of inserted stents varies in the published materials, which is a major cause of the varying results.</span></span></span></p></div>","PeriodicalId":101091,"journal":{"name":"Reviews in Vascular Medicine","volume":"1 4","pages":"Pages 76-80"},"PeriodicalIF":0.0,"publicationDate":"2013-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rvm.2013.08.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91335483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ankur Thapar , Alex Munster , Joseph Shalhoub , Alun Huw Davies
{"title":"Testing for asymptomatic carotid disease in patients with arterial disease elsewhere","authors":"Ankur Thapar , Alex Munster , Joseph Shalhoub , Alun Huw Davies","doi":"10.1016/j.rvm.2013.10.002","DOIUrl":"10.1016/j.rvm.2013.10.002","url":null,"abstract":"<div><p>Moderate to severe asymptomatic carotid atherosclerosis<span> is found in 2–7% of the European population aged over 60 years; however the prevalence is highest in those with peripheral arterial disease (25%).</span></p><p><span>The number of individuals needed to scan to prevent one extra stroke through referral for endarterectomy is 143 for claudicants, 250 for those with aortic aneurysmal disease and 333 for those with </span>contralateral<span> symptomatic carotid stenosis.</span></p><p>The cost per stroke saved with surgery is approximately £76,000, through a policy of testing claudicants for asymptomatic carotid atherosclerosis, then offering carotid endarterectomy. Through implementing large scale testing of claudicants aged 60 years in England and Wales, 0.2% of the total number of strokes per year would be saved at a cost of £17 million. The main cost driver is the amount of unnecessary surgery performed (number needed to treat=20).</p></div>","PeriodicalId":101091,"journal":{"name":"Reviews in Vascular Medicine","volume":"1 4","pages":"Pages 81-84"},"PeriodicalIF":0.0,"publicationDate":"2013-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rvm.2013.10.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76103182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}